Muneeb Ullah | Nanobiotechnology | Best Paper Award

Published on by ScienceFather

Mr. Muneeb Ullah | Nanobiotechnology | Best Paper Award

PhD Student | Pusan National University | South Korea

Mr. Muneeb Ullah is an accomplished nanomedicine researcher specializing in pharmaceutical nanotechnology, drug delivery systems, and biomaterials for therapeutic applications. His research primarily focuses on the synthesis and characterization of nanoparticles for wound healing, colorectal cancer, diabetic wound treatment, and inflammatory bowel diseases. He has published 38 scientific documents with 504 citations and an h-index of 11, reflecting strong and consistent contributions to high-impact biomedical research. Mr. Muneeb Ullah has authored numerous peer-reviewed journal papers and book chapters in leading outlets such as Chemical Engineering Journal, Small, Carbohydrate Polymer Technologies & Applications, European Polymer Journal, Journal of Pharmaceutical Investigation, and Current Problems in Cardiology. His works have collectively accumulated an impressive total impact factor exceeding 120. His notable contributions include advancements in nanoparticle-based therapeutics, 3D and 4D bioprinting, nanocarbon-based biomedical materials, and smart wound-healing systems. He has also co-authored multiple academic books and chapters published by CRC Press and Academic Press, covering topics such as fungal biotechnology, gastrointestinal inflammation, carbon dots, cancer nanomedicine, and nanotechnology in wound healing. His interdisciplinary collaborations have led to innovations in biofilm-associated therapies, tissue engineering, and targeted drug delivery systems. Recognized as a Best Researcher Award recipient in 2024 and 2025, Mr. Muneeb Ullah’s scholarly impact extends to editorial and reviewer services for international journals. His ongoing projects explore novel nanocluster adhesives, biopolymer-based nanostructures, and tumor-selective delivery mechanisms. Through his pioneering R&D initiatives, Mr. Muneeb Ullah continues to advance the frontiers of nanomedicine, combining pharmaceutical technology with molecular innovation to address complex biomedical challenges globally.

Profiles: Scopus | ResearchGate | Sci Profiles | Scholar GPS

Featured Publications

1. Safdar, M., Ullah, M., Hamayun, S., Wahab, A., Khan, S. U., Abdikakhorovich, S. A., Haq, Z. U., Mehreen, A., Naeem, M., Mustopa, A. Z., & Hasan, N. (2024). Microbiome miracles and their pioneering advances and future frontiers in cardiovascular disease. Current Problems in Cardiology, 49(9), 102686. https://doi.org/10.1016/j.cpcardiol.2024.102686

2. Khan, M. A., Khan, N., Ullah, M., Hamayun, S., Makhmudov, N. I., Mbbs, R., Safdar, M., Bibi, A., Wahab, A., Naeem, M., & Hasan, N. (2024). 3D printing technology and its revolutionary role in stent implementation in cardiovascular disease. Current Problems in Cardiology, 49(6), 102568. https://doi.org/10.1016/j.cpcardiol.2024.102568

3. Khan, S. U., Ullah, M., Saeed, S., Saleh, E. A. M., Kassem, A. F., Arbi, F. M., Wahab, A., Rehman, M., ur Rehman, K., Khan, D., … & Lu, K. (2024). Nanotherapeutic approaches for transdermal drug delivery systems and their biomedical applications. European Polymer Journal, 207, 112819. https://doi.org/10.1016/j.eurpolymj.2024.112819

4. Khan, S. U., Huang, Y., Ali, H., Ali, I., Ahmad, S., Khan, S. U., Hussain, T., Ullah, M., & Lu, K. (2024). Single-cell RNA sequencing (scRNA-seq): Advances and challenges for cardiovascular diseases (CVDs). Current Problems in Cardiology, 49(2), 102202. https://doi.org/10.1016/j.cpcardiol.2023.102202

5. Zeb, F., Mehreen, A., Naqeeb, H., Ullah, M., Waleed, A., Awan, U. A., Haider, A., & Naeem, M. (2024). Nutrition and dietary intervention in cancer: Gaps, challenges, and future perspectives. In Nutrition and Dietary Interventions in Cancer (pp. 281–307). Springer Nature Switzerland. https://doi.org/10.1007/978-3-031-55622-7_11

David Stejskal | Nanobiotechnology | Best Researcher Award

Published on by ScienceFather

Prof. Dr. David Stejskal | Nanobiotechnology | Best Researcher Award

Professor, MD, PhD, MBA, EuSpLM, Head of the Institute of Laboratory Medicine | University Hospital in Ostrava | Czech Republic

Prof. Dr. David Stejskal, MD, PhD, MBA, EuSpLM, is a distinguished researcher and academic leader in the field of laboratory medicine, clinical biochemistry, and internal medicine. His research primarily focuses on the identification and clinical validation of novel biomarkers relevant to metabolic, cardiovascular, nephrological, and inflammatory diseases. With over 3,767 citations, an h-index of 29 (Scopus), and more than 200 peer-reviewed publications, his scholarly influence spans translational diagnostics and clinical applications in metabolic and endocrine disorders. His most cited works include pioneering studies on fatty acid binding proteins (FABP), chemerin, and FGF23, which have significantly advanced understanding of biomarkers in metabolic syndrome, chronic kidney disease, and cardiovascular risk assessment. Prof. Dr. David Stejskal’s research group has also contributed substantially to the development of novel diagnostic markers for diabetes, obesity, and atherosclerosis, as well as the evaluation of inflammatory and oxidative stress parameters in internal medicine. Beyond journal publications, he has authored and co-authored several scientific books such as Metabolic Diseases of Mass Incidence, Dyslipidemia, and Urolithiasis, alongside chapters in specialized medical encyclopedias. His work has been instrumental in shaping biomarker-based diagnostic strategies across Central Europe. Prof. Dr. David Stejskal has received notable research and organizational recognitions, including the OMICS Award (USA) for excellence in translational medicine and the Czech Society of Clinical Biochemistry Award. As an editorial contributor, reviewer, and conference organizer, he has significantly influenced international collaboration in laboratory and clinical research. His continued focus on biochemical innovation, diagnostic optimization, and translational research highlights his contribution to advancing laboratory medicine and evidence-based clinical diagnostics globally.

Profiles: Scopus | ORCID | ResearchGate | Sci Profiles | Web of Science

Featured Publications

1. Sigutova, R., Evin, L., Kusnierova, P., Svagera, Z., Branny, M., & Vaclavik, J. (2025). Specific microRNAs for heart failure: Reference values in whole blood. Biomedicines, 13(10), 2559. https://doi.org/10.3390/biomedicines13102559

2. Urinovska, R., Sistik, P., Buzga, M., & Stejskal, D. (2024). Fast and easy simultaneous determination of riboflavin, folic acid, all-trans-retinol and α-tocopherol in human serum by LC/MS/MS for bariatric patients. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmae035

3. Johannsen, B., Baumgartner, D., Karpíšek, M., Paust, N., Zengerle, R., & Mitsakakis, K. (2024). Integration of a bead-based immunoassay on a commercial PCR-performing POC device. Proceedings, 2024(097166). https://doi.org/10.3390/proceedings2024097166

4. Johannsen, B., Baumgartner, D., Karpíšek, M., Paust, N., Zengerle, R., & Mitsakakis, K. (2023). Patient stratification for antibiotic prescriptions based on the bound-free phase detection immunoassay of C-reactive protein in serum samples. Biosensors, 13(12), 1009. https://doi.org/10.3390/bios13121009

5. Plášek, J., Lazárová, M., Dodulík, J., Švagera, Z., Všianský, F., & Václavík, J. (2022). Secretoneurin as a novel biomarker of cardiovascular episodes: Are we there yet? A narrative review. Journal of Clinical Medicine, 11(23), 7191. https://doi.org/10.3390/jcm11237191

Mr. Mulat Erkihun | Nanobiotechnology Awards | Best Researcher Award

Published on by ScienceFather

Mr. Mulat Erkihun | Nanobiotechnology Awards | Best Researcher Award

Mr. Mulat Erkihun, Debre Tabor University, Ethiopia

Mulat Erkihun Agaje is a dedicated medical microbiologist and lecturer at Debre Tabor University, Ethiopia. With extensive experience in both academic and clinical settings, he has contributed significantly to the field of microbiology. He has worked as a clinical microbiologist at Felege Hiwot Comprehensive Specialized Hospital and currently serves as a lecturer and clinical microbiologist at Debre Tabor University’s Medical Laboratory Sciences department. His research interests focus on infectious diseases, antimicrobial resistance, microbial genetics, and the application of nanomaterials in medical settings. Mulat is deeply committed to advancing microbiological research and education in Ethiopia, contributing to both scientific knowledge and the improvement of public health.

Professional Profile:

Orcid

Suitability for the Award:

Mulat Erkihun Agaje,  he is highly suitable for  Best Researcher Award due to his demonstrated excellence in medical microbiology, extensive research experience, and his significant contributions to public health, particularly in infectious diseases and antimicrobial resistance (AMR). Below is an assessment of his suitability for this prestigious recognition:

🎓Education :

Mulat Erkihun Agaje holds a Master of Science in Medical Microbiology from Bahir Dar University, which he completed in December 2019. During his postgraduate studies, he excelled in courses such as Advanced Medical Bacteriology, Virology, Immunology, and Microbial Genetics. His thesis focused on the antimicrobial resistance profile of Helicobacter pylori among patients in Bahir Dar, earning him an award of Very Great Distinction with a CGPA of 3.65/4.00. He also earned his Bachelor of Science in Medical Laboratory Science from Haramaya University in November 2016, graduating with a CGPA of 3.85/4.00. His undergraduate training included subjects such as Clinical Microbiology, Medical Virology, Epidemiology, and Biostatistics. Mulat’s academic journey laid a strong foundation for his career as a microbiologist and educator, fostering his commitment to advancing research and knowledge in medical microbiology.

🏢Experience :

Mulat Erkihun Agaje has more than seven years of experience in medical microbiology, with a focus on research, teaching, and clinical practice. He has been a lecturer at Debre Tabor University since March 2022, where he teaches Medical Laboratory Sciences students and is actively involved in research and community service. Prior to this, he worked as a Clinical Microbiologist at Felege Hiwot Comprehensive Specialized Hospital, where he supervised diagnostic microbiological services, developed Standard Operating Procedures (SOPs), and ensured the quality of laboratory services. He also served as a Medical Laboratory Technologist at the same institution from 2016 to 2020, where he conducted routine specimen analysis and supported disease diagnosis. In his current role, Mulat is responsible for conducting clinical microbiology services, research, and engaging in community-oriented health initiatives. His career trajectory reflects a strong commitment to medical education and public health improvement.

🏅Awards and Honors :

Mulat Erkihun Agaje has been recognized for his academic excellence and contributions to the field of medical microbiology. He was awarded “Very Great Distinction” for his Master’s degree at Bahir Dar University, graduating with a CGPA of 3.65/4.00. He was also among the top three students during his undergraduate studies at Haramaya University, earning the “Very Great Distinction” award with a CGPA of 3.85/4.00. These accolades reflect his dedication to his academic pursuits and his ability to excel in challenging coursework. Additionally, Mulat has received multiple awards for his research projects, including recognition at national conferences for his presentations on antimicrobial resistance and tuberculosis. His academic achievements and commitment to advancing medical microbiology in Ethiopia have established him as a respected figure in both the academic and healthcare sectors.

🔬Research Focus :

Mulat Erkihun Agaje’s research is centered on understanding microbial species that cause infectious diseases and their mechanisms of antimicrobial resistance (AMR). His work delves into the molecular genetics of pathogens, particularly Helicobacter pylori, and their resistance profiles, which are critical for improving diagnosis and treatment strategies. Mulat’s research interests extend to the molecular etiology of infectious diseases, where he employs modern molecular techniques in disease detection and management. He is also keen on exploring the application of nanomaterials in medical settings, particularly for improving diagnostic methods and therapeutic interventions. Mulat is involved in studying the pathogenesis of microbial infections and antimicrobial resistance, which is a growing concern in Ethiopia. His research aims to inform public health strategies, enhance clinical microbiology practices, and combat antimicrobial resistance in the country, contributing to the improvement of healthcare outcomes.

Publication Top Notes:

  • Catheter-associated Urinary Tract Infections in Africa: Systematic Review and Meta-analysis”
  • “Helicobacter pylori Isolate from Endoscopy Examined Patients in Bahir Dar, North West Ethiopia”
  • “The Role of Extracorporeal Photopheresis in the Management of Graft Versus Host Disease: Narrative Review”
  • “Antimicrobial-Resistance Profile of Helicobacter pylori, Obtained from Endoscopic Patients in Bahir Dar, North West Ethiopia”
  • “Tuberculosis Treatment Outcome and Associated Factors Among Tuberculosis Patients Linked to Tuberculosis Treatment Clinics in Ethiopia, 2023: A Multi-Center Retrospective Study”

 

 

 

 

 

Assist. Prof. Dr. Efthymia Iliana Matthaiou | Nanobiotechnology Awards | Best Researcher Award

Published on by ScienceFather

Assist. Prof. Dr. Efthymia Iliana Matthaiou | Nanobiotechnology Awards | Best Researcher Award

Assist. Prof. Dr. Efthymia Iliana Matthaiou, Albany Medical College, United States

Efthymia Iliana Matthaiou, PhD, is an Assistant Professor at Albany Medical College, NY, specializing in fungal infections and immunology. With a solid background in nanotechnology, immuno-oncology, and drug development, she leads cutting-edge translational research, developing novel therapies and diagnostics. Her expertise spans lung transplantation, cystic fibrosis, and autoimmune diseases. Dr. Matthaiou has a strong commitment to mentoring students, postdocs, and collaborators, and has been a key figure in advancing the study of fungal pathogens, including Aspergillus species. She holds several prestigious fellowships and grants, and has contributed significantly to scientific publications, particularly in the fields of immunology, transplantation, and nanomedicine.

Professional Profile:

Google Scholar

Orcid

Suitability for the “Best Researcher” Award: Efthymia Iliana Matthaiou, PhD

Summary of Suitability:

Dr. Efthymia Iliana Matthaiou is an exceptional candidate for the “Best Researcher” award due to her extensive and pioneering contributions in the fields of microbiology, immunology, and fungal infections. With a PhD from the University of Pennsylvania and Democritus University of Thrace, Dr. Matthaiou has advanced research into the molecular mechanisms of diseases such as cystic fibrosis and invasive fungal infections, focusing on immunomodulatory therapies and bioanalytical strategies.

🎓Education:

Dr. Matthaiou completed her postdoctoral training at Stanford University in 2020, focusing on lung immunology and transplantation. She earned her PhD from the University of Pennsylvania and Democritus University of Thrace in 2017, where her research centered on nanotechnology, immuno-oncology, and drug development. She graduated with the highest honors from Democritus University of Thrace with a BSc in 2011, marking the beginning of her promising scientific career.

🏢Experience:

Dr. Matthaiou is currently an Assistant Professor at Albany Medical College, where she leads a research laboratory focused on fungal infections and lung transplantation. Before this, she was a Lead Senior Scientist at Stanford University, leading several research initiatives on lung microenvironment, cystic fibrosis, and Aspergillus-related diseases. Her work includes developing immunomodulatory nanotherapies and studying host-pathogen interactions. She has also served as a postdoctoral researcher at Stanford, focusing on invasive aspergillosis in pediatric lung transplant patients and mentoring new hires and trainees.

🏅Awards and Honors:

Dr. Matthaiou has received several prestigious awards and fellowships, including the 2024 NCCAT-GUP3 Cryo-EM grant, for which she serves as Principal Investigator. She was also a Fellow of the 2022 Women’s Leadership Innovation Lab and received the 2019 Stanford MCHRI Postdoctoral Award, funding her research on innate immunity defects in cystic fibrosis and Aspergillus infections. These accolades highlight her leadership and contributions to the fields of immunology, transplantation, and infectious diseases.

🔬Research Focus:

Dr. Matthaiou’s research focuses on the intersection of fungal infections, immunology, and nanomedicine. Her work investigates the immune mechanisms that contribute to Aspergillus-related diseases, especially in the context of lung transplantation and cystic fibrosis. She is also exploring novel therapeutic approaches, such as nanoparticle-mediated drug delivery, to treat invasive aspergillosis. In addition, her research delves into macrophage dysregulation and its role in promoting fungal invasion, with the aim of developing immunomodulatory treatments to mitigate infection and improve patient outcomes.

Publication Top Notes:

  • Title: Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer
    • Cited by: 89
  • Title: Tumor endothelial marker 1–specific DNA vaccination targets tumor vasculature
    • Cited by: 78
  • Title: Iron: an essential nutrient for Aspergillus fumigatus and a fulcrum for pathogenesis
    • Cited by: 40
  • Title: Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma
    • Cited by: 36
  • Title: The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial
    • Cited by: 17

 

 

 

 

Dr. Anna Monzó-Martínez | Nanobiotechnology Awards | Best Researcher Award

Published on by ScienceFather

Dr. Anna Monzó-Martínez | Nanobiotechnology Awards | Best Researcher Award

Dr. Anna Monzó-Martínez , University of Valencia , Spain

Anna María Monzó Martínez is an Associate Professor at the Universitat de València, specializing in Educational Theory within the Faculty of Philosophy and Education Sciences. She holds degrees in Catalan Philology, Italian Philology, Psychology, and Psychopedagogy from Universitat de València and Universitat Oberta de Catalunya. Her research interests include psychosocial skills, higher education mobility, and the education of high-ability students. Dr. Monzó Martínez has published extensively in peer-reviewed journals, with notable articles addressing educational practices and global citizenship. Her work has been recognized in both national and international contexts, reflecting her significant contributions to educational research

Professional Profile:

Scopus

Orcid

Suitability for Best Researcher Award: Anna Maria Monzó Martínez:

Anna Maria Monzó Martínez is an accomplished academic with a strong background in education and psychology, particularly focusing on gifted education and teacher training. She  is Suitable For Best Researcher Awards .Her research contributions are significant, as evidenced by multiple publications in well-regarded national and international journals. The topics she explores, such as the psychosocial skills of highly capable students, teacher attitudes towards gifted education, and global citizenship education at the university level, are vital in shaping educational policies and practices.

🎓Education:

Anna María Monzó Martínez completed her academic studies with a focus on languages and education. She earned a degree in Filologia Catalana from the Universitat de València in 1997 and followed it with a degree in Filologia Italiana from the same institution in 1998. She further pursued higher education at the Universitat Oberta de Catalunya, where she obtained a Llicenciatura en Psicologia and a Llicenciatura en Psicopedagogia, with specific dates for these qualifications not provided.

🏢Work Experience:

Anna María Monzó Martínez has been serving as an Associate Professor in the Department of Educational Theory at the Universitat de València’s Faculty of Philosophy and Education Sciences since October 18, 2016. She has also worked as a lecturer within the same faculty, though specific dates for this role are not provided. Additionally, Dr. Monzó Martínez has engaged in various research projects and studies in the field of educational research, contributing significantly to the advancement of knowledge in her area of expertise.

🏆Awards:

Anna María Monzó Martínez has received recognition for her outstanding research contributions, highlighting her significant impact in the field of educational research. Although specific award details are not provided, this acknowledgment underscores her valuable work and influence in advancing educational practices and theories.

Publication Top Notes:

  • Teacher Attitudes Towards Serving Gifted Students in the Valencian Community. A Case Study | Actitud del profesorado hacia la atención al alumnado de alta capacidad. Estudio en la Comunidad Valenciana
  • Analysis of the Educational Response to Gifted Students | Anàlisi de la resposta educativa a l’alumnat d’alta capacitat
  • Teacher Training in Attention to Highly Gifted Students. Study in the Valencian Community (Spain) | Formación del profesorado en la atención al alumnado de alta capacidad. Estudio en la Comunidad Valenciana
    • Citations: 1

 

 

Dr. Muhammad Magdy | Nanobiotechnology Awards | Best Researcher Award

Published on by ScienceFather

Dr. Muhammad Magdy | Nanobiotechnology Awards | Best Researcher Award

Dr. Muhammad Magdy , Menoufia university, egypt

Muhammad Magdy Ahmed Abu-Elkomsan is a Lecturer in the Department of Basic Engineering Science at the Faculty of Engineering, Menoufia University, Egypt. Born on January 6, 1989, in Menoufia, Egypt, he specializes in Engineering Mechanics, with a particular focus on fluid mechanics, biofluid mechanics, and nanofluids. Dr. Abu-Elkomsan earned his Ph.D. in Engineering Mechanics in 2020 from Menoufia University, where he also completed his M.Sc. in 2016, focusing on mathematical models of peristaltic motion in fluids. His research interests include physiological flows, magnetohydrodynamics, and the study of fluid dynamics in biological systems. With a strong proficiency in scientific computing tools such as MATLAB, Mathematica, and Maple, he has been actively involved in teaching engineering mechanics and mathematics since 2012. Dr. Abu-Elkomsan is fluent in both Arabic and English, and he continues to contribute significantly to his field through research and teaching

Professional Profile:

Orcid

Summary of Suitability for Best Researcher Award:

Dr. Muhammad Magdy Ahmed Abu-Elkomsan, a Lecturer in the Department of Basic Engineering Science at Menoufia University, Egypt, demonstrates exceptional qualifications for the Best Researcher Award. His academic background, including a Ph.D. in Engineering Mechanics focused on “Flow of Nanofluids through Biological Systems,” and an M.Sc. on mathematical models of peristaltic motion, highlights his expertise in cutting-edge research areas. His work spans various complex topics such as fluid mechanics, biofluid mechanics, nanofluids, and magnetohydrodynamics, with a notable emphasis on physiological flows and their applications in medical and biological systems.

🎓Education:

Dr. Muhammad Magdy Ahmed Abu-Elkomsan holds a Ph.D. in Engineering Mechanics from the Department of Basic Engineering Science at Menoufia University, Egypt, completed in 2020. His doctoral thesis focused on “Flow of Nanofluids through Biological Systems.” He earned his M.Sc. in Engineering Mechanics from the same department in 2016, with a thesis titled “Study of Some Mathematical Models of Peristaltic Motion of Fluid with Suspended Particles.” Dr. Abu-Elkomsan completed his B.Sc. in Mechanical Power Engineering at Menoufia University in 2010, graduating with an overall rate of Very Good.

🏆Work Experience:

Dr. Muhammad Magdy Ahmed Abu-Elkomsan has been serving as a Lecturer in the Department of Basic Engineering Science at the Faculty of Engineering, Menoufia University, Shebin El-Kom, Egypt, since September 2020. Prior to this role, he worked as an Assistant Lecturer in the same department from August 2016 to August 2020. His academic career began as a Demonstrator in the Department of Basic Engineering Science, where he contributed from January 2012 to July 2016.

Publication Top Notes:

  1. The profound effect of heat transfer on magnetic peristaltic flow of a couple stress fluid in an inclined annular tube
  2. Synergistic Exploration of Heat Transfer for Integration Magnetohydrodynamics of Nanofluids Peristaltic Transport within Annular Tubes
  3. The Impact of Heat Transfer and a Magnetic Field on Peristaltic Transport with Slipping through an Asymmetrically Inclined Channel
  4. Benchmarking the Composite Performance of Distinct Shapes of Ferrometallic Gold Nanoshells: Photothermal Cancer Therapy
  5. Conjugate dissipative radiative heating with thermal slipping and the entropy production on the thrust of MHD gold blood nanofluid with curvature effects

 

 

Dr. Muhammad Nisar Ul Haq | Nanobiotechnology Awards | Innovation in Nanomaterials Prize

Published on by ScienceFather

Dr. Muhammad Nisar Ul Haq | Nanobiotechnology Awards | Innovation in Nanomaterials Prize

Dr. Muhammad Nisar Ul Haq , Department of Botany Hazara University Mansehra KP Pakistan Department of Biotechnology , Pakistan

Dr. Muhammad Nisar Ul Haq is a recent Ph.D. graduate in Botany from Hazara University, Mansehra, having earned his degree in 2023 with a GPA of 3.46. He also holds an M.Phil. in Botany from UST Bannu and an MSc in Botany from the same institution. Dr. Haq’s research focuses on the synthesis of green silver nanoparticles and their effects on diabetes, with notable publications in journals such as Nanomaterials and Sains Malaysiana. He has accumulated teaching experience as an internee at GDC Kakki Bannu and currently serves as a visiting faculty member at the Department of Zoology, UST Bannu. His expertise includes lab work related to phytotoxicity, antibacterial and antifungal activities, and various other biological assays. Dr. Haq is proficient in computer skills including MS Office and internet applications.

Professional Profile:

Orcid

Summary of Suitability for Innovation in Nanomaterials Prize

Dr. Muhammad Nisar Ul Haq is highly suitable for the Innovation in Nanomaterials Prize due to his significant contributions to the field of nanomaterials, particularly in the green synthesis of silver nanoparticles. His research demonstrates innovation in sustainable nanomaterials production and their potential therapeutic applications, particularly in the treatment of diabetes. Dr. Ul Haq’s work stands out due to its interdisciplinary approach, combining expertise in botany and nanotechnology to address real-world health issues. His publications in high-impact journals further underline his contributions to the field and his potential to drive further innovation in nanomaterial.

🎓Education:

Dr. Muhammad Nisar Ul Haq earned his Ph.D. in Botany from Hazara University, Mansehra, in 2023, with a GPA of 3.46. He completed his M.Phil. in Botany at UST Bannu in 2016, achieving a CGPA of 3.42. His earlier academic background includes an MSc in Botany from UST Bannu in 2009, where he secured 2424 out of 3300 marks. He obtained his BSc from DMU DIKhan in 2007, with 292 out of 550 marks. Dr. Haq’s foundational education includes an F.Sc from BISE Bannu in 2005, where he scored 654 out of 1100 marks, and an SSC from BISE Bannu in 2002, with 561 out of 800 marks.

🏢Work Experience:

Dr. Muhammad Nisar Ul Haq is currently serving as a Visiting Faculty member in the Department of Zoology at UST Bannu. Prior to this, he gained valuable experience as an internee at GDC Kakki Bannu, where he worked for one year.

Publication Top Notes:

  • Biogenic Synthesis of Silver Nanoparticles Using Phagnalon niveum and Its In Vivo Anti-Diabetic Effect against Alloxan-Induced Diabetic Wistar Rats
  • Green Silver Nanoparticles Synthesized from Taverniera couneifolia Elicits Effective Anti-Diabetic Effect in Alloxan-Induced Diabetic Wistar Rats by Muhammad Nisar Ul Haq, Prof. Dr. Ghulam Mujtaba Shah, Farid Menaa, Rahmat Ali Khan, Norah Althobaiti, Aishah Albalawi, Huda Alkreathy